Fo
Forma (Novo)
Watertown MAFounded 2007200 employees
Private CapbiotechAcquiredHematology
Platform: SCD HbF
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tirasacituzumab | FOR-8447 | NDA/BLA | 1 | BET | OCD | ||
| FOR-6391 | FOR-6391 | Preclinical | 2 | IL-13 | WM |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (1)